Skip to content
Screener

Oric Pharmaceuticals, Inc. ORIC Other Non-Current Assets

Other Non-Current Assets at other companies

ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$156K-11.4%
CG Oncology logo
CG OncologyCGON
$4.73M-82.3%
NTH
Neonc Technologies HoldingsNTHI
$47.18K0.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$116.54M-11.8%
RFL
Rafael Holdings, Inc.RFL
$2.12M+23.6%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$4.38M-35.6%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$1.4B+78.5%
Enterprise value$1.35B+89.2%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-204047
Line itemMarch 31, 2026December 31, 2025
Total current assets290,233288,466
Long-term investments137,779110,762
Property and equipment, net2,1472,415
Other assets6,6037,247
Total assets$436,762$408,890
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$2,895$3,824

Item 1. Financial Statements.

FAQ

What is Oric Pharmaceuticals, Inc.'s other non-current assets?
Oric Pharmaceuticals, Inc. (ORIC) reported other non-current assets of $6.6M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
Oric Pharmaceuticals, Inc.'s other non-current assets decreased by 21.1% year-over-year, from $8.37M to $6.6M.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s other non-current assets has grown at a 86.8% compound annual growth rate (CAGR), from $319K to $7.25M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Oric Pharmaceuticals, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude